NFE2L2 and gastric cancer: Consistent with these findings, data from The Cancer Genome Atlas database showed that CARM1 and NRF2 were significantly upregulated in gastric cancer (Fig. 1F), and the higher expression levels of NRF2 and CARM1 were negatively correlated with the overall survival times of patients with gastric cancer (Fig. 1G).